Clinical Trial Update: FrActional Flow Reserve Guided Drug Coated Balloon Only Strategy in De Novo coronarY Lesions (FADDY) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a drug-coated balloon-only strategy guided by fractional flow reserve for de novo coronary lesions; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Stenosis

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Coronary Stenosis | Phase 3 | Status: UNKNOWN